iRemedy Healthcare

iRemedy Healthcare

Growth Stage

Solving the pain of today's medical supply chain with Artificial Intelligence

Solving the pain of today's medical supply chain with Artificial Intelligence

Overview

Raised to Date: Raised: $237,787

Total Commitments ($USD)

Platform

Republic

Start Date

02/12/2023

Close Date

09/30/2023

Min. Goal
$850
Max. Goal
$25,000,000
Min. Investment

$850

Security Type

Equity - Common

Series

Series B

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share

$8.50

Pre-Money Valuation

$302,000,000

Rolling Commitments ($USD)

Status
Funded
Reporting Date

10/30/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$1,034

# of Investors

149

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2007

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B/B2C

Margin

Low

Capital Intensity

Low

Location

Stuart, Florida

Business Type

High Growth

iRemedy Healthcare is raising funds on Republic through Reg A+ crowdfunding. The company is using artificial intelligence to solve the issues of the medical supply chain. The business has created a large procurement marketplace for doctors and hospitals to get lifesaving supplies easily at transparent pricing and with constant supply monitoring. iRemedy Healthcare has over 10,000 customers, 500,000 products, and generated $52 million in revenue in 2022. Tony Paquin and Gary Paquin founded iRemedy Healthcare in 2007. The current crowdfunding campaign has a maximum target of $25 million. The campaign proceeds will be used for acquisition and investment opportunities, growth strategies, and working capital.

Balance Sheet

Cash and Cash Equivalents

$198,144

Accounts and Notes Receivable

$226,428

Total Assets

$25,390,782

Accounts Payable & Accrued Liabilities

$46,315,177

Long Term Debt

$776,366

Total Liabilities

$56,452,283

Total Stockholders' Equity

$-31,751,217

Total Liabilities and Equity

$25,390,782

Statement of Comprehensive Income Information

Total Revenues

$50,227,530

Costs & Expenses Applicable to Rev

$48,929,498

Depreciation and Amortization

$123,586

Net Income

$-14,847,660

Earnings Per Share - Basic

$-0.43

Earnings Per Share - Diluted

$-0.43

Auditor: WithumSmith+Brown, PC
Financials as of: 02/12/2023
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
iRemedy Healthcare 02/12/2024 Dalmore Group - $6,375 Equity - Common Funded RegA+
iRemedy Healthcare 09/30/2023 Republic $302,000,000 $237,787 Equity - Common Funded RegA+
Create a free account today to gain access to KingsCrowd analytics.

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Valuation History

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Add to portfolio
iRemedy Healthcare on Republic 2023
Platform: Republic
Security Type: Equity - Common
Valuation: $302,000,000
Price per Share: $8.50

Follow company

Follow iRemedy Healthcare on Republic 2023

Buy iRemedy Healthcare's Deal Report

Warning: according to the close date for this deal, iRemedy Healthcare may no longer be accepting investments.

iRemedy Healthcare Deal Report

Get KingsCrowd’s comprehensive report on iRemedy Healthcare including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether iRemedy Healthcare is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the iRemedy Healthcare deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge